J&J offers $5.5bn to settle baby powder lawsuits
Johnson & Johnson has proposed a $5.5bn settlement to resolve nearly 70,000 US lawsuits alleging its talc products cause cancer.
The update
Johnson & Johnson has proposed a $5.5bn settlement to resolve tens of thousands of US lawsuits alleging its talc-based baby powder caused ovarian cancer. The deal covers approximately 69,000 cases in federal and state courts, representing about 99.75% of outstanding talc-related claims. The settlement requires acceptance by 95% of claimants before it can be finalized. J&J maintains the allegations are meritless and that its products are safe. The company plans to pay up to $3bn next year, with no additional payments due before 2028.
Why it matters
This proposed settlement marks a significant step toward resolving a decade-long legal battle for the healthcare giant. It could provide financial relief to thousands of plaintiffs while allowing J&J to focus on its medical mission. However, the deal is contingent on court approval and may face pushback from plaintiffs’ attorneys if the terms fall short of expectations. The resolution also highlights the ongoing scrutiny of talc products, following the World Health Organization’s classification of talc as probably carcinogenic to humans in 2024.
What to watch
Watch for court approval of the settlement and the percentage of claimants who accept the terms. Monitor whether J&J admits any liability or if this remains a purely financial resolution. Additionally, track the status of other pending or future talc-related lawsuits outside this deal, particularly in the UK where a major product liability case is ongoing.
Sources
- bbc.co.uk — details on the $5.5bn offer, payment schedule, and J&J's denial of liability.
- aljazeera.com — the number of lawsuits covered (nearly 70,000) and the UK case status.